Home › Stocks › ESLA › Changes

Who bought & sold ESLA (Q3 2026)

Funds holding (Q3 2026)16
New positions2
Added3
Reduced4
Exited2

As of Q3 2026, 16 institutional funds reported holding ESLA (Estrella Immunopharma Inc Com): 2 opened new positions, 3 added, 4 trimmed and 2 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (2)

Fund Shares Value Weight
Citadel Advisors New 27.55K $12.86K —
Citigroup Inc New 5.91K $2.76K —

Added to positions (3)

Fund Shares Value Weight Change
VANGUARD FIDUCIARY TRUST CO 94.40K $44.08K — +29.48K sh (+45.4%)
Tower Research Capital LLC (TRC) 6.50K $3.03K — +3.19K sh (+96.5%)
BlackRock Inc 52.87K $24.67K — +836 sh (+1.6%)

Reduced positions (4)

Fund Shares Value Weight Change
ARMISTICE CAPITAL, LLC 3.67M $1.71M 0.0 -305.44K sh (-7.7%)
Renaissance Technologies 14.70K $6.86K — -24.40K sh (-62.4%)
UBS Group AG 1.36K $633 — -365 sh (-21.2%)
BARCLAYS PLC 2 $1 — -124 sh (-98.4%)

Exited positions (2)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
GEODE CAPITAL MANAGEMENT, LLC Exited 141.32K $146.97K —
US BANCORP \DE\ Exited 20.00K $20.80K —